It bought back nearly $9 billion of its own shares in 2019. “We will focus instead on increasing the dividend and investing in the business during this period of growth,” said Chief Financial Officer …

More UPDATE 3-Pfizer profit misses estimates as revenue falls; plans no 2020 share repurchases Videos